ApprovalTrail

Approval · Notice of Compliance 3288 · 1997

RHONORMIN: Notice of Compliance 3288

Issued July 16, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3288
Date
July 16, 1997
Company
Rhodiapharm IncLaval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Beta-adrenergic receptor blocking agent

Products in this notice

BrandDINStatus today
RHONORMIN02231731Cancelled Post Market
RHONORMIN02231733Cancelled Post Market

Medicinal ingredients